» Articles » PMID: 30464571

Evaluation of Chemokine CXCL10 in Human Gingival Crevicular Fluid, Saliva, and Serum As Periodontitis Biomarker

Overview
Journal J Inflamm Res
Publisher Dove Medical Press
Date 2018 Nov 23
PMID 30464571
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of this study was to evaluate CXCL10 as a biomarker for periodontitis by determining the CXCL10 levels in saliva, serum, and gingival crevicular fluid (GCF) samples from periodontally healthy control subjects and adult subjects with chronic periodontitis.

Patients And Methods: Adult patients seeking dental treatment at Umm Al-Qura University dental clinic underwent a complete periodontal examination, and saliva, serum, and GCF samples were collected. Subjects were classified as chronic periodontitis patients (n=31) if they have a periodontal probing depth (PD) of ≥4 mm and/or clinical attachment level (CAL) of ≥3 mm in >30% of the teeth. The control group (n=25) had PD ≤3 mm and/or CAL ≤2 mm. ELISA was performed to determine the concentration of CXCL10 in saliva, serum, and GCF samples. Student's -test was carried out to evaluate the significant difference between different groups. Spearman's correlation test was used to analyze the relationship between the levels of CXCL10 and the clinical periodontal parameters. -value of ≤0.05 was considered significant.

Results: Significantly higher concentrations of CXCL10 were found in saliva and serum in chronic periodontitis patients as compared with the controls (272±60.4 pg/mL and 72±13.4 pg/mL vs 130±22.2 pg/mL and 44.08±4.5 pg/mL, ≤0.05). The CXCL10 levels in GCF were higher in the periodontitis group as compared with the control group (66.36±32.0 pg/mL and 44.56±17.5 pg/mL, respectively); the difference did not reach statistical significance (≥0.05). Moreover, serum CXCL10 level was significantly higher in periodontitis patients with moderate to severe bone loss as compared with those with mild bone loss (71.05±4.7 pg/mL vs 54.8±7.7 pg/mL, ≤0.05). The serum CXCL10 levels were found to be related to CAL measurements (=0.3, =0.026), while the saliva CXCL10 levels were related to PD measurements (=0.8, =0.0007).

Conclusion: CXCL10 is significantly increased in periodontitis subjects as compared with controls and could be used as a marker for periodontal disease.

Citing Articles

Oral and Gingival Crevicular Fluid Biomarkers for Jawbone Turnover Diseases: A Scoping Review.

Fadli N, Abdul Rahman M, Karsani S, Ramli R Diagnostics (Basel). 2024; 14(19).

PMID: 39410587 PMC: 11475764. DOI: 10.3390/diagnostics14192184.


Salivary IL-1β, IL-6, and IL-10 Are Key Biomarkers of Periodontitis Severity.

Relvas M, Mendes-Frias A, Goncalves M, Salazar F, Lopez-Jarana P, Silvestre R Int J Mol Sci. 2024; 25(15).

PMID: 39125970 PMC: 11312971. DOI: 10.3390/ijms25158401.


The role of periodontitis in cancer development, with a focus on oral cancers.

Farhad S, Karbalaeihasanesfahani A, Dadgar E, Nasiri K, Esfahaniani M, Nabi Afjadi M Mol Biol Rep. 2024; 51(1):814.

PMID: 39008163 DOI: 10.1007/s11033-024-09737-6.


Convergence of inflammatory response: Salivary cytokine dynamics in coronavirus disease 2019 and periodontal disease.

Gupta S, Mohindra R, Ramola M, Kanta P, Singla M, Malhotra M J Indian Soc Periodontol. 2024; 28(1):113-121.

PMID: 38988958 PMC: 11232810. DOI: 10.4103/jisp.jisp_508_23.


Serum biomarker levels in smokers and non-smokers following periodontal therapy. A prospective cohort study.

Knie L, Leknes K, Xue Y, Lie S, Bunaes D BMC Oral Health. 2024; 24(1):463.

PMID: 38627806 PMC: 11020793. DOI: 10.1186/s12903-024-04196-8.


References
1.
Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela M, Gamonal J . Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. J Periodontol. 2005; 75(12):1586-91. DOI: 10.1902/jop.2004.75.12.1586. View

2.
Taub D, Lloyd A, Conlon K, Wang J, Ortaldo J, Harada A . Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 1993; 177(6):1809-14. PMC: 2191047. DOI: 10.1084/jem.177.6.1809. View

3.
Beltran-Aguilar E, Eke P, Thornton-Evans G, Petersen P . Recording and surveillance systems for periodontal diseases. Periodontol 2000. 2012; 60(1):40-53. PMC: 4530316. DOI: 10.1111/j.1600-0757.2012.00446.x. View

4.
Almehmadi A, AlGhamdi F . Biomarkers of alveolar bone resorption in gingival crevicular fluid: A systematic review. Arch Oral Biol. 2018; 93:12-21. DOI: 10.1016/j.archoralbio.2018.05.004. View

5.
Yim H, Park C, Lee Y, Arimoto K, Jeon R, Baek S . Elevated Response to Type I IFN Enhances RANKL-Mediated Osteoclastogenesis in Usp18-Knockout Mice. J Immunol. 2016; 196(9):3887-95. DOI: 10.4049/jimmunol.1501496. View